Antagonism of stromal cell-derived factor-1alpha reduces infarct size and improves ventricular function after myocardial infarction (Q47286962)

13 January 2018

title

Antagonism of stromal cell-derived factor-1alpha reduces infarct size and improves ventricular function after myocardial infarction (English)

1 reference

13 January 2018

main subject

myocardial infarction

1 reference

Cindy Proulx

1

1 reference

13 January 2018

Viviane El-Helou

2

1 reference

13 January 2018

Hugues Gosselin

3

1 reference

13 January 2018

Robert Clement

4

1 reference

13 January 2018

Marc-Antoine Gillis

5

1 reference

13 January 2018

Louis Villeneuve

6

1 reference

13 January 2018

Angelino Calderone

7

1 reference

13 January 2018

publication date

23 May 2007

1 reference

13 January 2018

published in

Pfluegers Archiv

1 reference

13 January 2018

volume

455

1 reference

13 January 2018

page(s)

241-250

1 reference

13 January 2018

issue

2

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s00424-007-0284-5

exact match

0 references

cites work

Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00424-007-0284-5

Resident nestin+ neural-like cells and fibers are detected in normal and damaged rat myocardium.

21 January 2018

1 reference

12 December 2020

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

1 reference

12 December 2020

Crucial Role of Stromal Cell–Derived Factor-1α in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice

1 reference

12 December 2020

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

12 December 2020

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

1 reference

12 December 2020

Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis

1 reference

12 December 2020

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

1 reference

12 December 2020

A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression

1 reference

12 December 2020

Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction

1 reference

12 December 2020

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

12 December 2020

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

12 December 2020

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

1 reference

12 December 2020

Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes

1 reference

12 December 2020

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

1 reference

12 December 2020

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

12 December 2020

Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy

1 reference

12 December 2020

Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis

1 reference

12 December 2020

Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.

1 reference

12 December 2020

Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.

1 reference

12 December 2020

AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post‐MI

1 reference

12 December 2020

Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction

1 reference

12 December 2020

Bone marrow cells regenerate infarcted myocardium

1 reference

12 December 2020

Effects of sarcoplasmic reticulum Ca2+-ATPase overexpression in postinfarction rat myocytes

1 reference

12 December 2020

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

12 December 2020

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

1 reference

12 December 2020

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

12 December 2020

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

1 reference

12 December 2020

Nitric oxide-mediated inhibition of DNA synthesis was attenuated in hypertrophied neonatal rat ventricular myocytes

1 reference

12 December 2020

CXCR4 modulates contractility in adult cardiac myocytes

1 reference

12 December 2020

PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice

1 reference

12 December 2020

10.1007/S00424-007-0284-5

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

17520275

1 reference

13 January 2018